Progynyの空売り状況は、投資家がProgynyの株価下落に賭けている度合いを知ることができます。空売りデータは2週間ごとに更新されます。

Progyny (NASDAQ:PGNY) 株価情報, 空売り情報

Progyny

Progyny Inc is a company engaged in specializing in fertility and family building benefits solutions. Its clients include employers across various industries. The fertility benefits solution consists of the treatment services (Smart Cycles), access to the Progyny network of high-quality fertility specialists that perform the Smart Cycle treatments and active management of the selective network of high-quality provider clinics.

News

Price Target

Pre-Market Outlook

Markets

Analyst Ratings

CTSH

FTNT

ICHR

OMGA

PGNY

UBER

トップ・ウォール街のアナリストたちは、これらの銘柄に対する見通しを変更しました。リーディング・アナリストのレーティング変更の総見については、アップグレードやダウングレードを含むすべての情報については、当社のアナリストのレーティングページをご覧ください。

ウーバー株上昇相場を示唆　アナリストが解説

Progyny Inc

Hartshead Resources NL

Fourth Quarter and Fiscal 2024 Guidance
Looking ahead, Ms. Rentler said, "For the 13 weeks ending February 1, 2025, we continue to project comparable store sales to increase 2% to 3%. Earnings per share for the fourth quarter are planned to be in the range of $1.57 to $1.64, compared to $1.82 for the 14 weeks ended February 3, 2024. This guidance range includes an unfavorable impact of approximately $0.03 per share primarily from the timing of packaway-related expenses that benefited the third quarter. Based on our year-to-date results and fourth quarter forecast, earnings per share for the 52 weeks ending February 1, 2025 are now expected to be in the range of $6.10 to $6.17 versus $5.56 last year. As a reminder, both the 2023 fourth quarter and full year results included an approximate $0.20 earnings per share benefit from the 53rd week."
Ms. Rentler concluded, "We remain confident that our ongoing focus and commitment to delivering the most compelling values possible will enable us to maximize our potential for profitable growth now and in the future."
The Company will host a conference call on Thursday, November 21, 2024 at 4:15 p.m. Eastern time to provide additional details concerning its third quarter results and management's outlook for the remainder of the year. A real-time audio webcast of the conference call will be available in the Investors section of the Company's website, located at <a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.rossstores.com%2F&amp;esheet=54156543&amp;newsitemid=20241121923724&amp;lan=en-US&amp;anchor=www.rossstores.com&amp;index=1&amp;md5=bfa4905ac7dbfebd087535fc992a2eb9">www.rossstores.com</a>. An audio playback will be available at 201-612-7415, PIN #13749868 until 8:00 p.m. Eastern time on November 29, 2024, as well as on the Company's website.

Guidance

ROST

Ross Stores Sees Q4 EPS $1.57-$1.64 Vs $1.67 Est.; Comparable Store Sales To Increase 2% To 3%; FY25 EPS $6.10-$6.17 Vs $6.13 Est.

WIIM

Ross Stores shares are trading higher after the company reported better-than-expected Q3 EPS results.

Elastic (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ESTC#NYSE">ESTC</a>) reported quarterly earnings of $0.59 per share which beat the analyst consensus estimate of $0.38 by 55.26 percent. The company reported quarterly sales of $365.361 million which beat the analyst consensus estimate of $355.900 million by 2.66 percent. This is a 17.63 percent increase over sales of $310.612 million the same period last year.

Earnings

Earnings Beats

ESTC

Elastic Q2 2025 Adj. EPS $0.59 Beats $0.38 Estimate, Sales $365.361M Beat $355.900M Estimate

Logility Supply Chain (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LGTY#NASDAQ">LGTY</a>) reported quarterly earnings of $0.11 per share which beat the analyst consensus estimate of $0.09 by 22.22 percent. The company reported quarterly sales of $25.30 million which missed the analyst consensus estimate of $25.94 million by 2.47 percent. This is a 1.52 percent decrease over sales of $25.69 million the same period last year.

Earnings Misses

LGTY

Logility Supply Chain Q2 2025 Adj EPS $0.11 Beats $0.09 Estimate, Sales $25.30M Miss $25.94M Estimate

<h3>Gainers</h3>
<ul>
<li>Wag Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PET#NASDAQ">PET</a>) stock rose 23.8% to $0.26 during Thursday's pre-market session. The market value of their outstanding shares is at $12.9 million. </li>
<li>Interactive Strength (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRNR#NASDAQ">TRNR</a>) stock increased by 15.04% to $4.13. The company's market cap stands at $2.5 million. </li>
<li>Worksport (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WKSP#NASDAQ">WKSP</a>) shares increased by 12.76% to $0.56. The company's market cap stands at $18.5 million. </li>
<li>Dream Finders Homes (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DFH#NYSE">DFH</a>) stock moved upwards by 11.07% to $31.0. The market value of their outstanding shares is at $2.9 billion. </li>
<li>Universal Technical (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UTI#NYSE">UTI</a>) stock moved upwards by 10.15% to $21.91. The market value of their outstanding shares is at $1.1 billion. As per the news, the Q4 earnings report came out yesterday. </li>
<li>Genius Gr (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/GNS#AMEX">GNS</a>) stock moved upwards by 9.43% to $1.04. The company's market cap stands at $22.5 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Cato (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CATO#NYSE">CATO</a>) shares decreased by 13.8% to $5.24 during Thursday's pre-market session. The company's market cap stands at $107.7 million. As per the news, the Q3 earnings report came out today. </li>
<li>Yunji (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/YJ#NASDAQ">YJ</a>) shares decreased by 13.07% to $1.73. The company's market cap stands at $34.0 million. The company's, Q3 earnings came out today. </li>
<li>Digital Brands Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DBGI#NASDAQ">DBGI</a>) shares decreased by 12.52% to $0.12. The company's market cap stands at $4.5 million. </li>
<li>PDD Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PDD#NASDAQ">PDD</a>) stock fell 10.32% to $104.47. The market value of their outstanding shares is at $145.0 billion. As per the press release, Q3 earnings came out today. </li>
<li>Container Store Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TCS#NYSE">TCS</a>) shares decreased by 9.75% to $3.89. The company's market cap stands at $13.4 million. </li>
<li>Autozi Internet Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AZI#NASDAQ">AZI</a>) stock decreased by 6.01% to $1.88. The market value of their outstanding shares is at $197.3 million. 
See Also: <a href="http://www.benzinga.com/money/best-consumer-cyclical-stocks/" title="www.benzinga.com/money/best-consumer-cyclical-stocks/">www.benzinga.com/money/best-consumer-cyclical-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Movers

CATO

DBGI

Citigourp Global Markets 2% Protected Notes Linked To The Djia

TRNR

WKSP

12 Consumer Discretionary Stocks Moving In Thursday's Pre-Market Session

<h3>Gainers</h3>
<ul>
<li>SCWorx (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WORX#NASDAQ">WORX</a>) shares moved upwards by 71.4% to $1.68 during Thursday's pre-market session. The market value of their outstanding shares is at $2.7 million. </li>
<li>Conduit Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CDT#NASDAQ">CDT</a>) stock rose 55.36% to $0.14. The market value of their outstanding shares is at $14.7 million. </li>
<li>Cidara Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CDTX#NASDAQ">CDTX</a>) shares rose 28.96% to $19.5. The market value of their outstanding shares is at $137.4 million. </li>
<li>Semler Scientific (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMLR#NASDAQ">SMLR</a>) stock rose 27.46% to $75.55. The company's market cap stands at $548.9 million. </li>
<li>Biodexa Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BDRX#NASDAQ">BDRX</a>) stock increased by 16.88% to $4.5. The market value of their outstanding shares is at $65.3 million. </li>
<li>DarioHealth (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DRIO#NASDAQ">DRIO</a>) stock increased by 14.1% to $0.89. The market value of their outstanding shares is at $30.3 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Pyxis Oncology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PYXS#NASDAQ">PYXS</a>) stock fell 43.5% to $2.16 during Thursday's pre-market session. The company's market cap stands at $128.3 million. </li>
<li>Perspective Therapeutics (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/CATX#AMEX">CATX</a>) shares declined by 27.23% to $4.49. The market value of their outstanding shares is at $303.4 million. </li>
<li>Kura Oncology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KURA#NASDAQ">KURA</a>) stock decreased by 25.52% to $11.85. The company's market cap stands at $921.5 million. </li>
<li>BioLine Rx (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLRX#NASDAQ">BLRX</a>) stock decreased by 22.42% to $0.42. The company's market cap stands at $33.8 million. </li>
<li>Silexion Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLXN#NASDAQ">SLXN</a>) stock declined by 20.0% to $0.27. The market value of their outstanding shares is at $3.8 million. </li>
<li>Assembly Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASMB#NASDAQ">ASMB</a>) stock fell 11.06% to $13.36. The market value of their outstanding shares is at $84.9 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ASMB

BDRX

BLRX

CATX

CDTX

DRIO

KURA

PYXS

SLXN

SMLR

WORX

12 Health Care Stocks Moving In Thursday's Pre-Market Session

<h3>Gainers</h3>
<ul>
<li>Safe Pro Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPAI#NASDAQ">SPAI</a>) stock increased by 94.1% to $6.21 during Thursday's pre-market session. The company's market cap stands at $85.4 million. </li>
<li>SKK Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SKK#NASDAQ">SKK</a>) shares rose 31.57% to $6.0. The company's market cap stands at $93.7 million. </li>
<li>Palladyne AI (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PDYN#NASDAQ">PDYN</a>) shares increased by 18.55% to $2.3. The company's market cap stands at $69.2 million. </li>
<li>CRA Intl (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRAI#NASDAQ">CRAI</a>) stock increased by 12.59% to $216.88. The market value of their outstanding shares is at $1.4 billion. </li>
<li>HUHUTECH International Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HUHU#NASDAQ">HUHU</a>) stock increased by 10.0% to $4.4. The company's market cap stands at $92.6 million. </li>
<li>Titan Machinery (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TITN#NASDAQ">TITN</a>) stock moved upwards by 9.68% to $15.41. The company's market cap stands at $356.4 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Agrify (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AGFY#NASDAQ">AGFY</a>) stock fell 28.9% to $27.57 during Thursday's pre-market session. The company's market cap stands at $42.1 million. </li>
<li>noco-noco (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NCNC#NASDAQ">NCNC</a>) shares decreased by 14.98% to $0.14. The market value of their outstanding shares is at $26.6 million. </li>
<li>Nauticus Robotics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KITT#NASDAQ">KITT</a>) stock decreased by 12.84% to $0.95. The company's market cap stands at $6.0 million. </li>
<li>Caravelle Intl Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HTCO#NASDAQ">HTCO</a>) stock declined by 10.45% to $1.2. The market value of their outstanding shares is at $66.9 million. </li>
<li>EHang Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EH#NASDAQ">EH</a>) shares declined by 9.23% to $13.87. The market value of their outstanding shares is at $881.5 million. As per the press release, Q3 earnings came out 3 days ago. </li>
<li>Atkore (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ATKR#NYSE">ATKR</a>) stock fell 8.76% to $76.78. The company's market cap stands at $2.7 billion. The company's, Q4 earnings came out today. 
See Also: <a href="http://www.benzinga.com/money/best-industrials-stocks/" title="www.benzinga.com/money/best-industrials-stocks/">www.benzinga.com/money/best-industrials-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AGFY

ATKR

CRAI

HTCO

HUHU

KITT

NCNC

PDYN

SPAI

TITN

12 Industrials Stocks Moving In Thursday's Pre-Market Session

<h3>Gainers</h3>
<ul>
<li>Snowflake (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNOW#NYSE">SNOW</a>) stock rose 24.5% to $160.8 during Thursday's pre-market session. The market value of their outstanding shares is at $53.9 billion. The company's, Q3 earnings came out yesterday. </li>
<li>Akoustis Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AKTS#NASDAQ">AKTS</a>) shares moved upwards by 22.04% to $0.11. The company's market cap stands at $16.4 million. </li>
<li>Aurora Mobile (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JG#NASDAQ">JG</a>) shares rose 21.62% to $9.0. The company's market cap stands at $53.8 million. </li>
<li>ZenaTech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZENA#NASDAQ">ZENA</a>) stock rose 21.05% to $1.84. The market value of their outstanding shares is at $32.5 million. </li>
<li>Cerence (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRNC#NASDAQ">CRNC</a>) shares rose 18.08% to $3.33. The company's market cap stands at $139.2 million. As per the press release, Q4 earnings came out today. </li>
<li>Quantum Computing (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QUBT#NASDAQ">QUBT</a>) stock moved upwards by 15.48% to $4.25. The market value of their outstanding shares is at $502.4 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>SEALSQ (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LAES#NASDAQ">LAES</a>) stock decreased by 15.2% to $0.42 during Thursday's pre-market session. The company's market cap stands at $12.4 million. </li>
<li>Cemtrex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CETX#NASDAQ">CETX</a>) stock decreased by 11.29% to $0.21. </li>
<li>Wellchange Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WCT#NASDAQ">WCT</a>) shares declined by 8.73% to $3.03. The market value of their outstanding shares is at $64.4 million. </li>
<li>CSP (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSPI#NASDAQ">CSPI</a>) stock declined by 7.82% to $12.51. The market value of their outstanding shares is at $122.1 million. </li>
<li>Backblaze (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLZE#NASDAQ">BLZE</a>) stock decreased by 7.71% to $5.75. The market value of their outstanding shares is at $255.3 million. </li>
<li>Castellum (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/CTM#AMEX">CTM</a>) stock decreased by 5.36% to $0.16. The market value of their outstanding shares is at $8.9 million. 
See Also: <a href="http://www.benzinga.com/money/tech-stocks/" title="www.benzinga.com/money/tech-stocks/">www.benzinga.com/money/tech-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AKTS

BLZE

CETX

CRNC

CSPI

LAES

QUBT

SNOW

ZENA

12 Information Technology Stocks Moving In Thursday's Pre-Market Session

REPL

Replimune Receives Breakthrough Therapy Designation For RP1, Submits RP1 Biologics License Application To FDA Under Accelerated Approval Pathway

INTU

Intuit shares are trading lower after the company issued Q2 adjusted EPS and revenue guidance below analyst estimates.

Forward-looking Guidance
Intuit reiterated guidance for the full fiscal year 2025. The company expects:
<ul>
<li>Revenue of $18.160 billion to $18.347 billion, growth of approximately 12 to 13 percent.</li>
<li>GAAP operating income of $4.649 billion to $4.724 billion, growth of approximately 28 to 30 percent.</li>
<li>Non-GAAP operating income of $7.241 billion to $7.316 billion, growth of approximately 13 to 14 percent.</li>
<li>GAAP diluted earnings per share of $12.34 to $12.54, growth of approximately 18 to 20 percent.</li>
<li>Non-GAAP diluted earnings per share of $19.16 to $19.36, growth of approximately 13 to 14 percent.</li>
</ul>
The company also reiterated full fiscal year 2025 segment revenue guidance:
<ul>
<li>Global Business Solutions Group: growth of 16 to 17 percent. This includes Online Ecosystem revenue growth of approximately 20 percent, and Desktop Ecosystem revenue growth in the low single digits.</li>
<li>Consumer Group: growth of 7 to 8 percent.</li>
<li>ProTax Group: growth of 3 to 4 percent.</li>
<li>Credit Karma: growth of 5 to 8 percent.</li>
</ul>

Intuit Sees FY25 EPS $19.16-$19.36 Vs $19.33 Est.; Revenue $18.16B-$18.347B Vs $18.26B Est.

AAPL

Apple Aims To Launch Siri Revamp In 2026 With More In-House AI

NTAP

NetApp shares are trading higher following better-than-expected Q2 financial results.

Intuit announced guidance for the second quarter of fiscal year 2025, which ends January 31. The company expects:
<ul>
<li>Revenue of $3.812 billion to $3.845 billion, growth of approximately 13 to 14 percent. The company expects a single digit decline in Consumer Group revenue due to some promotional changes in retail channels largely related to its desktop offering. This only impacts revenue timing and does not impact overall unit or revenue expectations for fiscal year 2025. The company expects Global Business Solutions Group Desktop Ecosystem revenue to return to growth in the second quarter.</li>
<li>GAAP diluted earnings per share of $0.84 to $0.90.</li>
<li>Non-GAAP diluted earnings per share of $2.55 to $2.61.</li>
</ul>

Intuit Sees Q2 Adj. EPS $2.55-$2.61 Vs $3.25 Est.; Revenue $3.812B-$3.845B Vs $3.88B Est.

<a href="https://storage.courtlistener.com/recap/gov.uscourts.txnd.395430/gov.uscourts.txnd.395430.30.0.pdf" title="https://storage.courtlistener.com/recap/gov.uscourts.txnd.395430/gov.uscourts.txnd.395430.30.0.pdf">https://storage.courtlistener.com/recap/gov.uscourts.txnd.395430/gov.uscourts.txnd.395430.30.0.pdf</a>

MSTR

MicroStrategy Completes $3B Offering Of 0% Convertible Senior Notes Due 2029, Including $400M Option Exercised By Initial Purchasers

Abacus intends to use net proceeds of the primary portion of the offering for its operations, including the purchase of life settlement policies, to support its overall business strategy, for working capital purposes, and for general corporate purposes, which may include funding previously announced and future acquisitions and repayment and refinancing of its indebtedness. Abacus will receive no proceeds from the secondary portion of the offering.

Offerings

Abacus Life Commences Public Offering Of 12.50M Shares Of Its Common Stock, Including 10M Shares By  Company And 2.50M To Be Sold By Certain Stockholders

NetApp Sees Q3 FY25 Revenue $1.61B-$1.76B, GAAP EPS $1.41-$1.51, Non-GAAP EPS $1.85-$1.95; Sees FY25 Revenue $6.54B-$6.74B, GAAP EPS $5.48-$5.68, Non-GAAP EPS $7.20-$7.40

Highly anticipated movies "Wicked" and "Gladiator II" are being released on the same day and come shortly ahead of "Moana 2," setting up what could be a record-breaking Thanksgiving weekend for the <a href="https://www.benzinga.com/news/earnings/24/11/41790068/amc-ceo-is-confident-and-optimistic-about-cinema-chains-future-as-q3-earnings-show-revenue-beat-rec">movie theater industry</a>.
What Happened: "Wicked" and "Gladiator II" open in domestic movie theaters on Nov. 22, in a move that some compared to the release of "Barbie" and "Oppenheimer" on the<a href="https://www.benzinga.com/general/entertainment/24/07/39621420/wicked-gladiator-2-same-day-release-has-industry-vying-for-another-box-office-power-duo-bar"> same day last year.</a>
While "Glicked" or whatever acronym you want to use for seeing both movies the same day didn't catch on as big as last year's "Barbenheimer" did previously, expectations remain high for both movies.
"Wicked," which comes from Comcast Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMCSA#NASDAQ">CMCSA</a>) unit Universal Pictures, is expected to post a domestic opening weekend total in the range of $125 million to $150 million, as <a href="https://deadline.com/2024/11/wicked-gladiator-box-office-preview-1236181463/">reported </a>by Deadline.
"Gladiator II," which comes from Paramount Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PARA#NASDAQ">PARA</a>)(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PARAA#NASDAQ">PARAA</a>), is expected to have a domestic opening weekend of more than $60 million.
Deadline reports strong initial audience scores for "Wicked" from those who saw early screenings of the film and pre-sales that are "through the roof."
As an R-rated movie, a total of $60 million or more could help "Gladiator II" become the highest-grossing R-rated film in November.
Read Also: <a href="https://www.benzinga.com/general/entertainment/24/11/41987956/airbnb-says-are-you-not-entertained-new-roman-colosseum-experience-coincides-with-gladiator-sequel">Airbnb Says &#8216;Are You Not Entertained?&#8217; New Roman Colosseum Experience Coincides With Gladiator Sequel</a>
Why It's Important: The strong expected opens for "Wicked" and "Gladiator II" could be good news for AMC Entertainment Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMC#NYSE">AMC</a>) and Cinemark Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNK#NYSE">CNK</a>) and other movie theater operators in the U.S.
Along with those two movies, movie theaters could also benefit from the release of "Moana 2" from Walt Disney Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIS#NYSE">DIS</a>), which comes next Wednesday, ahead of the Thanksgiving holiday.
The three movies could help the domestic box office pass $300 million and hit all-time records for the holiday five-day weekend, <a href="https://www.hollywoodreporter.com/movies/movie-news/box-office-record-thanksgiving-feast-1236067367/">according </a>to The Hollywood Reporter.
With three strong movies all released shortly before Thanksgiving, estimates predict a strong domestic box office next week, which could be another bright spot in the post-COVID-19 recovery for movie theaters and movie companies.
A total of over $300 million, with most coming from the three films, could come close to the record. Here's a look at the current top-grossing five-day domestic Thanksgiving weekends and the highest-grossing film during the time period:
<ul>
<li>2018: $315.6 million, "Ralph Breaks the Internet" ($84.8 million)</li>
<li>2013: $294.2 million, "The Hunger Games: Catching Fire" ($109.9 million)</li>
<li>2017: $270.5 million, "Coco" ($72.9 million)</li>
<li>2019: $263.4 million, "Frozen II" ($125.0 million)</li>
<li>2016: $260.0 million, "Moana" ($125.0 million)</li>
</ul>
The report said current tracking predicts "Moana 2" will gross between $125 million and $150 million for the five-day holiday weekend domestically, which would break records for the time period.
The early Wednesday opening could contribute to the strong expectations for "Moana 2" as not all blockbusters haven't done this same holiday release window previously, the report added.
While the strong opening expectations for the three films could help the movie companies behind them, the big winners will likely be the movie theaters as they could see many customers coming in more than once during a period that might have only drawn one visit in past years due to this year's strong lineup.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/general/entertainment/24/07/39718738/elon-musk-predicts-gladiator-sequel-will-be-painfully-bad-embarrassingly-so-films-star-says">Elon Musk Predicts Gladiator Sequel Will Be &#8216;Painfully Bad. Embarrassingly So&#8217;: Film&#8217;s Star Says Movie Takes &#8216;New Direction&#8217;</a></li>
</ul>
Photo: Movie posters via IMDb

Entertainment

Trading Ideas

CMCSA

PARA

PARAA

'Wicked,' 'Gladiator II,' 'Moana 2' Could Break Thanksgiving Weekend Box Office: Stocks To Watch

Management

FLUX

Flux Power Chairman & CEO Ron Dutt To Retire

Ross Stores (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ROST#NASDAQ">ROST</a>) reported quarterly earnings of $1.48 per share which beat the analyst consensus estimate of $1.40 by 5.71 percent. This is a 11.28 percent increase over earnings of $1.33 per share from the same period last year. The company reported quarterly sales of $5.07 billion which missed the analyst consensus estimate of $5.15 billion by 1.45 percent. This is a 2.97 percent increase over sales of $4.92 billion the same period last year.

Ross Stores Q3 EPS $1.48 Beats $1.40 Estimate, Sales $5.07B Miss $5.15B Estimate

JMP Securities analyst Constantine Davides maintained a Hold rating on Progyny (PGNY – Research Report) today. The company's shares closed yesterda...

Progyny (PGNY) Receives a Hold from JMP Securities

Truist downgraded Progyny (PGNY) to Hold from Buy with a price target of $19, down from $26. The firm says that while the company's net member addi...

Progyny downgraded to Hold from Buy at Truist

Barclays analyst Stephanie Davis assigned a Buy rating to Progyny (PGNY – Research Report) today and set a price target of $30.00. The company's sh...

Barclays Issues a Buy Rating on Progyny (PGNY)

J.P. Morgan analyst Anne Samuel has maintained their bullish stance on PGNY stock, giving a Buy rating today. Anne Samuel has given his Buy rating ...

Positive Long-Term Outlook for Progyny Amidst Short-Term Challenges

BofA lowered the firm's price target on Progyny (PGNY) to $21 from $22 and keeps a Buy rating on the shares. Q3 results highlight ongoing pressure ...

Progyny price target lowered to $21 from $22 at BofA

Progyny stock plunges 18% amid lowered guidance, Truist downgrade

Jefferies lowered the firm's price target on Progyny (PGNY) to $19 from $24 and keeps a Buy rating on the shares. The firm is lowering estimates to...

Progyny price target lowered to $19 from $24 at Jefferies

Barclays analyst Stephanie Davis lowered the firm's price target on Progyny (PGNY) to $17 from $30 and keeps an Overweight rating on the shares. Th...

Progyny price target lowered to $17 from $30 at Barclays

Progyny: After A Terrible Year, I'm Out (Rating Downgrade)

Zoetis: This Beautifully Boring, Slow-Growing Compounder Is A Buy

BIIB

BNTX

ELAN

IDXX

MRNA

VRTX

Press Releases

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Progyny, Inc. - PGNY

Legal

Progyny (PGNY) Client Retention Narrative Under Examination - Hagens Berman

Health Care

Progyny, Inc. Announces Details for Its Third Quarter 2024 Results Report

Johnson Fistel has Commenced an Investigation on Behalf of Progyny (PGNY) Shareholders

Comments

Progyny

空売り

Progyny (NASDAQ:PGNY) 株価情報, 空売り情報

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル